Cipla Therapeutics Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Cipla Therapeutics Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Cipla Therapeutics Inc.

Cipla Therapeutics Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by PLAZOMICIN. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: complicated urinary, tract infections, cuti including, patients years, age older, only limited, clinical safety, efficacy data. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
PLAZOMICIN 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Cipla Therapeutics Inc.

Brand nameGenericTypeRoute
Zemdri (plazomicin) PLAZOMICIN HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Cipla Therapeutics Inc. make?
1 FDA drug label records name Cipla Therapeutics Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Cipla Therapeutics Inc. produce?
The most frequent active ingredients in this portfolio are PLAZOMICIN.

Are Cipla Therapeutics Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.